ATE281457T1 - Trizyklische verbindungen mit einer spiro-einheit - Google Patents

Trizyklische verbindungen mit einer spiro-einheit

Info

Publication number
ATE281457T1
ATE281457T1 AT00940912T AT00940912T ATE281457T1 AT E281457 T1 ATE281457 T1 AT E281457T1 AT 00940912 T AT00940912 T AT 00940912T AT 00940912 T AT00940912 T AT 00940912T AT E281457 T1 ATE281457 T1 AT E281457T1
Authority
AT
Austria
Prior art keywords
tricyclic compounds
useful
relates
inhibitor
spiro unit
Prior art date
Application number
AT00940912T
Other languages
English (en)
Inventor
Hidemitsu Nishida
Fumihiko Saitoh
Kousuke Harada
Ikuya Shiromizu
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Application granted granted Critical
Publication of ATE281457T1 publication Critical patent/ATE281457T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
AT00940912T 1999-06-30 2000-06-30 Trizyklische verbindungen mit einer spiro-einheit ATE281457T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22288399 1999-06-30
PCT/JP2000/004374 WO2001002397A1 (en) 1999-06-30 2000-06-30 Tricyclic compounds having spiro union

Publications (1)

Publication Number Publication Date
ATE281457T1 true ATE281457T1 (de) 2004-11-15

Family

ID=16789385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940912T ATE281457T1 (de) 1999-06-30 2000-06-30 Trizyklische verbindungen mit einer spiro-einheit

Country Status (21)

Country Link
EP (1) EP1191028B1 (de)
JP (1) JP4890707B2 (de)
KR (1) KR20020015061A (de)
CN (1) CN1371375A (de)
AT (1) ATE281457T1 (de)
AU (1) AU774397B2 (de)
BR (1) BR0012093A (de)
CA (1) CA2380852C (de)
CZ (1) CZ20014696A3 (de)
DE (1) DE60015541T2 (de)
HK (1) HK1049157A1 (de)
HU (1) HUP0202188A3 (de)
IL (1) IL147348A0 (de)
MX (1) MXPA02000003A (de)
NO (1) NO20016402L (de)
NZ (1) NZ516363A (de)
PL (1) PL352862A1 (de)
SK (1) SK19292001A3 (de)
TR (1) TR200103853T2 (de)
WO (1) WO2001002397A1 (de)
ZA (1) ZA200110558B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187023A1 (en) * 2000-07-17 2003-10-02 Keiji Kubo Sulfone derivatives, process for their production and use thereof
WO2002053568A1 (en) * 2000-12-28 2002-07-11 Mochida Pharmaceutical Co., Ltd. Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds
EP1569912B1 (de) 2002-12-03 2015-04-29 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidinderivate als faktor vii-a hemmer
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
WO2006006490A1 (ja) * 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
WO2006106804A1 (ja) 2005-03-31 2006-10-12 Mochida Pharmaceutical Co., Ltd. 環内窒素原子にアシル基が結合した三環系スピロ化合物
WO2007136085A1 (ja) 2006-05-23 2007-11-29 Mochida Pharmaceutical Co., Ltd. スピロ四環系化合物
US7739434B2 (en) 2008-01-11 2010-06-15 International Business Machines Corporation Performing a configuration virtual topology change and instruction therefore

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE136032T1 (de) * 1987-07-20 1996-04-15 Duphar Int Res 8,9-anellierte 1,2,3,4-tetrahydro-beta-carbolin- derivate
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles

Also Published As

Publication number Publication date
WO2001002397A1 (en) 2001-01-11
AU774397B2 (en) 2004-06-24
SK19292001A3 (sk) 2002-06-04
EP1191028B1 (de) 2004-11-03
HK1049157A1 (zh) 2003-05-02
KR20020015061A (ko) 2002-02-27
WO2001002397A9 (en) 2001-04-05
EP1191028A4 (de) 2002-10-23
CA2380852C (en) 2009-10-20
CZ20014696A3 (cs) 2002-05-15
DE60015541T2 (de) 2005-12-08
NO20016402D0 (no) 2001-12-28
MXPA02000003A (es) 2003-07-21
CA2380852A1 (en) 2001-01-11
HUP0202188A2 (en) 2002-10-28
DE60015541D1 (de) 2004-12-09
NO20016402L (no) 2002-02-27
TR200103853T2 (tr) 2002-11-21
HUP0202188A3 (en) 2004-04-28
EP1191028A1 (de) 2002-03-27
PL352862A1 (en) 2003-09-08
NZ516363A (en) 2004-05-28
BR0012093A (pt) 2002-07-16
JP4890707B2 (ja) 2012-03-07
AU5572000A (en) 2001-01-22
ZA200110558B (en) 2002-09-12
CN1371375A (zh) 2002-09-25
IL147348A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
EA200400387A1 (ru) Азабициклические замещённые конденсированные гетероарильные соединения для лечения заболеваний
CY1109183T1 (el) Συντηγμενες ετεροκυκλικες ενωσεις και χρηση αυτων ως αναστολεας hcv πολυμερασης
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
BRPI0407810A (pt) composto, composição farmacêutica, ativador da glicocinase, e, medicamento
DK1487444T3 (da) Anvendelse af pyridylamider som angiogeneseinhibitorer
ATE554085T1 (de) Neue inhibitoren von glutaminylcyclase
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
ATE372767T1 (de) Dpp-iv-hemmer
EA200800485A1 (ru) Макроциклические ингибиторы вируса гепатита с
BR0213660A (pt) Composto, composição farmacêutica e método para tratar pacientes
NO20053794L (no) N-(1-benzyl-2-oxo-2-(1-piperazinyl) etyl)-1-piperidinkarboksamid-derivater og relaterte forbindelsers bruk som CGRP-antagonister for behandling av hodepine.
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
MY139461A (en) Condensed furan compounds
DE60015541D1 (de) Trizyklische verbindungen mit einer spiro-einheit
ATE337318T1 (de) Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
WO2002026732A1 (en) Benzodiazepine derivative
AR028802A1 (es) El uso de ciertos compuestos de ftalazina para el tratamiento de enfermedades neovasculares oculares
ATE347558T1 (de) Cephem verbindungen und diese enthaltende esbl nachweisreagenzien
BRPI0918966A8 (pt) composto inibidor de proteases, composição farmacêutica compreendendo dito compostos e uso terapêutico do mesmo
WO2007020411A8 (en) Amide derivatives
CY1108241T1 (el) Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
DE60013515D1 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
EA200301062A1 (ru) Фармацевтические комбинации на основе производных пиридоиндолона и противораковых агентов
DE50104100D1 (de) Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties